JP Morgan Chase
TSVT

JP Morgan Chase’s 2seventy bio TSVT Stock Holding History

JP Morgan Chase’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,765
Closed -$137K – 7650
2025
Q1 		$137K Sell
27,765
-454,439
-94% -$1.44M ﹤0.01% 5416
2024
Q4 		$1.42M Sell
482,204
-32,563
-6% -$134K ﹤0.01% 4386
2024
Q3 		$2.43M Sell
514,767
-17,665
-3% -$79.7K ﹤0.01% 3853
2024
Q2 		$2.05M Sell
532,432
-431,280
-45% -$1.94M ﹤0.01% 3769
2024
Q1 		$5.16M Sell
963,712
-50,304
-5% -$237K ﹤0.01% 3083
2023
Q4 		$4.33M Sell
1,014,016
-337,851
-25% -$1.04M ﹤0.01% 3218
2023
Q3 		$5.3M Buy
1,351,867
+179,653
+15% +$1.18M ﹤0.01% 2798
2023
Q2 		$11.9M Sell
1,172,214
-411,467
-26% -$4.36M ﹤0.01% 2153
2023
Q1 		$16.2M Buy
1,583,681
+601,147
+61% +$6.87M ﹤0.01% 1850
2022
Q4 		$9.21M Buy
982,534
+58,292
+6% +$822K ﹤0.01% 2336
2022
Q3 		$13.4M Buy
924,242
+33,059
+4% +$491K ﹤0.01% 1917
2022
Q2 		$11.8M Buy
891,183
+408,376
+85% +$5.56M ﹤0.01% 2020
2022
Q1 		$8.24M Sell
482,807
-21,997
-4% -$373K ﹤0.01% 2567
2021
Q4 		$12.9M Buy
+504,804
New +$15.7M ﹤0.01% 2217

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

JP Morgan Chase's TSVT Position: Q2 2025 in Review

JP Morgan Chase sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 27,765 shares — an estimated $137K sold.

JP Morgan Chase first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $16.2M in Q1 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • JP Morgan Chase reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 27,765 2seventy bio shares in Q2 2025, an estimated $137K.
  • JP Morgan Chase first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • JP Morgan Chase's 2seventy bio position peaked at $16.2M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.